Skip to main content

Psyence Biomedical Ltd.

PBMWW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001985062

No open-market purchases or sales by Psyence Biomedical Ltd. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $121.6K in total; no superinvestor holds it.

Other share classesPBM

Q1 2024 vs. Q4 2023

How the institutions holding Psyence Biomedical Ltd. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of PBMWW: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders030+30
Shares06.76M+6.76M
Value$0$499.9K+$499.9K

New holders (30)

Institutions that held Psyence Biomedical Ltd. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to PBMWW in Q1 2024
InstitutionSharesValue% of portfolio
EHP Funds Inc.1,232,748$86.3K0.06%
Cantor Fitzgerald, L. P.468,500$59.9K0.01%
Polar Asset Management Partners Inc.733,000$51.3K0.00%
MMCAP International Inc. SPC600,000$42.0K0.01%
Calamos Advisors LLC500,000$35.8K0.00%
Saba Capital Management, L.P.297,847$21.3K0.00%
Periscope Capital Inc.300,000$21.0K0.01%
Aristeia Capital LLC272,857$19.5K0.00%
Clear Street Derivatives LLC277,919$19.5K0.00%
Context Capital Management, LLC234,200$16.4K0.00%
LMR Partners LLP200,000$14.0K0.00%
Walleye Capital LLC198,296$13.9K0.00%
Clear Street LLC180,276$12.6K0.00%
D. E. Shaw & Co., Inc.175,352$12.6K0.00%
Shaolin Capital Management LLC175,000$12.2K0.00%
Tenor Capital Management Co., L.P.150,000$10.5K0.00%
Wolverine Asset Management LLC134,917$9.44K0.00%
Cowen and Company, LLC130,287$9.12K0.00%
Westchester Capital Management, LLC92,073$6.59K0.00%
Yakira Capital Management, Inc.76,843$5.38K0.00%
Mizuho Securities USA LLC89,325$4.47K0.00%
Mint Tower Capital Management B.V.50,000$4.00K0.00%
Flow State Investments, L.P.55,000$3.85K0.00%
Whitebox Advisors LLC50,000$3.50K0.00%
Walleye Trading LLC24,354$1.71K0.00%
Schonfeld Strategic Advisors LLC24,300$1.70K0.00%
SkyView Investment Advisors, LLC17,500$1.00K0.00%
Ancora Advisors, LLC5,000$3500.00%
UBS Group AG73$50.00%
Anson Funds Management LP12,500––

Sold out (0)

Institutions that held Psyence Biomedical Ltd. at the end of Q4 2023 and filed for Q1 2024 without it.

None.